Hiatt sponsors Biotech, Health & Science Forum (11/12)
Jun. 08, 2013
Brandeis University’s 5th Annual
Biotech, Health & Science Forum
“Technology’s role in advancing health outcomes”
Tues., November 12, 2013, 5:30 – 8:30 p.m.*
Sherman Hall, Hassenfeld Conference Center
*Please note the event timeline.
Check out the program guide now!
View photos from last year's event.
Explore careers in health and science from research and clinical to product development and public health. Learn about fields, pathways and problems being solved by organizations through direct exposure and discussions with alumni and other current professionals. Sponsored by the Hiatt Career Center, the Biotech, Health and Science Forum will feature a pre-reception for alumni and table hosts, an expert panel presentation and round table networking sessions for students, alumni and employer guests.
This year's theme - technology’s role in advancing health outcomes - aims to increase attendees’ awareness of the growing opportunities to impact health and human life, while also gaining a better understanding of just how connected different parts of the health sector really are. The panelists will speak about the unique ways their organizations are improving patient outcomes from preventative health to discovery and bench research to business innovation.
5:30 p.m. | Alumni & Table Host Registration & Networking Reception
Table hosts and Boston-based alumni in biotech, health, and science-related fields will get the chance to network with one another at this on-campus cocktail pre-reception, co-sponsored by the Hiatt Career Center and the Boston Alumni Club. The reception will be held in the Luria reception room. Drinks and light refreshments will be provided. Register here.
6:00 p.m. | Student Registration
6:30 p.m. | Panel Discussion: Technology’s Role in Advancing Health Outcomes
Alumni, students and table host volunteers are invited to attend this panel discussion moderated by Steve Usdin, senior editor at BioCentury. The panelists will speak about the unique ways their organizations are improving patient outcomes from preventative health to discovery and bench research to business innovation. Regardless of their roles or paths, each of the event's industry guests all have a passion for addressing unmet needs in health and helping students and alumni with their career paths. Alumni panelists include:
- Willis Chandler ’97, M.B.A., Executive Vice President, Shields Pharmacy Services (view bio)
- Kimberly Lindfield, PhD ’96, Director of Biostatistics at Cubist Pharmaceuticals (view bio)
- Jon Waldstreicher '05, , M.D., M.B.A., Principal at Apple Tree Partners principal at Apple Tree Partners (view bio)
- Moderator: Steve Usdin, Senior Editor at BioCentury (view bio)
Can't make the live event? The alumni panel will be streamed live online beginning at 6:30 p.m. Register here to tune in remotely and join the conversation on Twitter with #deisforum. This portion of the event is sponsored in partnership with the Brandeis Alumni Association.
7:15 p.m. | Round Table Networking for Students & Table Hosts
Following the panel discussion, students will rotate to different networking tables hosted by alumni and industry volunteers to learn about their organization, job function and career paths. Alumni guests will be invited to return to the reception venue at this time.
Undergraduate Students: RSVP via B.hired > Events > Forums
Graduate Students & Post-docs: RSVP here
Alumni: RSVP here
Online Video Stream: All online attendees RSVP here
Professional dress is strongly recommended.
Make the most of your opportunity to meet professionals/table hosts at the Biotech, Health & Science Forum on 11/7! Learn how to research organizations in advance, participate in the networking round tables, and develop questions and responses that set you apart - essential preparation for this great career event.
RSVP via B.hired > Events > Workshops
Steve has been Washington Editor of BioCentury since 1993, and has spent the past 20 years in the nation's capital covering political and policy issues affecting the life sciences sector. He also is the host of BioCentury This Week, BioCentury's weekly public affairs television program, as well as BioCentury Senior Editor responsible for coverage of social issues involving biotechnology.
Steve’s reporting about biotechnology and biomedical policy has been cited in The Economist, The Wall Street Journal, the Washington Post, New Scientist and other publications. In 2012, the FDA Alumni Association named Steve the Harvey W. Wiley Lecturer, making him the first journalist to receive the Wiley Award. His book, “Engineering Communism: How Two Americans Spied for Stalin and Founded the Soviet Silicon Valley,” was published in 2005 by Yale University Press.
Willis Chandler is the Executive Vice President of Shields Pharmacy Services. Shields is a pharmacy services company focused on building integrated and comprehensive ambulatory pharmacies with Hospitals and IDNs that are owned and branded by the health system. Through these pharmacies and their unique integration with the patient’s care team, the Shields Pharmacy care model improves medication adherence and outcomes for a hospital’s most complex patients. In his role as EVP, Willis is responsible for the strategic planning and hospital integration for the company’s Specialty Pharmacy and Home Infusion divisions.
Prior to joining Shields Pharmacy Services in 2011, Willis was the Senior Vice President of Business Development for the UMass Memorial Health Care, which is a $2.5B system in Worcester, Massachusetts. He was responsible for developing the UMass Memorial clinical network including the Academic Medical Center, four owned and eight affiliated community hospitals, and a 1,000 employed physician Medical Group. During his tenure at UMass Memorial, Willis has held various management positions within its Academic Medical Center including oversight of the ICUs, eICU, the Neurosciences Service Line and Capital Planning. Prior to joining UMass Memorial in 2003, Willis held various management positions at Cambridge Health Alliance including overseeing Quality and Budgeting for Primary Care.
Willis earned his Bachelor of Arts from Brandeis University in Waltham, MA, and his Masters of Business Administration from the Wharton School of Business in Philadelphia, PA. Willis has been involved with the United Way of Central Massachusetts and lives outside of Boston, MA.
Kimberly Lindfield currently holds the position of Director, Biometrics at Cubist Pharmaceuticals, where she is leading cross-functional teams in clinical development of novel drugs in the acute care setting. Cubist's clinical product pipeline currently consists of a Phase 3 program focused on the development of a novel cephalosporin to address certain serious infections caused by multi-drug resistant (MDR) Gram-negative organisms, a Phase 3 program for the treatment of CDAD, a Phase 3 program for the treatment of chronic opioid induced constipation (OIC) in patients with chronic non-cancer pain, and a Phase 3 program for the treatment of certain Gram-positive infections, including MRSA.
Prior to the past 12 years working in the Biotech/Pharmaceutical industry as a Clinical Research Scientist, Kim spent the first 5 years of her career as an Assistant Research Professor at the Boston University School of Medicine where she conducted original research in the areas of language and memory disorders and neuropsychology.
Kim received both a M.A. in Psychology and Ph.D. in Neuroscience from Brandeis University, and she is currently completing an M.B.A. at Bentley University with a concentration in Management.
Jonathan Waldstreicher, M.D., M.B.A., is a Principal at Apple Tree Partners, a large partnership that is using venture capital, private equity, and other investment vehicles to build a new life sciences company. At Apple Tree, Jon leads an acquisition, investment, and startup strategy in a new medical device category.
Prior to joining Apple Tree, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where he initiated and led an investment strategy and R&D development program in a new growth platform technology area. He started at Johnson & Johnson as an Associate Director in the Corporate Office of Science & Technology where he executed numerous seed grants to startup companies and participated in technical diligence of venture capital investments. Before medical school, Jon worked in Equity Research at Bear Stearns.
Jon received a B.A. from Brandeis University in Economics and an M.D. and M.B.A. from Tufts University School of Medicine where he was awarded the Norman Stearns award for highest achievement and overall excellence within the dual degree program. Between his third and fourth year of medical school, Jon worked as a fellow at the Corporate Office of Science & Technology at J&J. He completed a General Surgery Internship at Tufts Medical Center in Boston.
Apple Tree Partners
BioCentury Publications, Inc.
Boston Health Care for the Homeless Program
Center for Health Information and Analysis (CHIA)
DMFishman Consulting Services
Fulcrum Research Group
Genetic Services, Inc
Greenberg Trauring, LLP
Harvard School of Public Health
Joslin Diabetes Center
Life Science Nation
Beth Israel Deaconess Medical Center
Massachusetts Life Science Center
Medical Information Technology, Inc. (MEDITECH)
Memorial Sloan Kettering Cancer Center
New England Family Health Center
PrepMD Professionals LLC
Research Triangle Institue (RTI)
Safe Passage Neuromonitoring
Shields Pharmacy Services
The Institute for Clinical and Economic Review (ICER) at MGH
Waltham Urgent Care Center